CymitQuimica logo
mTOR

mTOR

mTOR inhibitors are compounds that inhibit the activity of Mammalian Target of Rapamycin (mTOR), a central regulator of cell growth, proliferation, metabolism, and survival. The mTOR pathway is frequently altered in cancer and other diseases, making mTOR a critical target for therapeutic intervention. Inhibitors of mTOR are widely used in research related to cancer, aging, and metabolic disorders. At CymitQuimica, we offer a variety of mTOR inhibitors to support your research in signal transduction, oncology, and therapeutic development.

Found 163 products for "mTOR".

products per page.
  • PI3K-IN-37
    Targetmol
    + Info

    PI3K-IN-37

    CAS:
    PI3K-IN-37 inhibits PI3K α/β/δ (IC50: 6/8/4 nM) and mTOR (IC50: 4 nM).
    Formula:C25H26N6O2
    Color and Shape:Solid
    Molecular weight:442.51

    Ref: TM-T62580

  • LGB321 monohydrochloride
    Targetmol
    + Info

    LGB321 monohydrochloride

    CAS:
    LGB321 monohydrochloride is an effective, selective, and orally active ATP-competitive small molecule inhibitor that targets all three PIM kinases. It inhibits proliferation, the mTOR-C1 signaling pathway, and BAD phosphorylation in various blood cancer-derived cell lines. LGB321 monohydrochloride is suitable for research on hematological malignancies.
    Formula:C23H23ClF3N5O2
    Molecular weight:493.91

    Ref: TM-T208966

  • AZD 3147
    Targetmol
    + Info

    AZD 3147

    CAS:
    AZD 3147 inhibits mTORC1 (40.7 nM), mTORC2 (5.75 nM), and PI3Kα/β/δ/γ (912/5495/9333/6310 nM IC50s).
    Formula:C24H31N5O4S2
    Purity:99.99%
    Color and Shape:Solid
    Molecular weight:517.66

    Ref: TM-T36200